Annual report of the Australian Meningococcal Surveillance Programme, 1999

Authors

  • Australian Meningococcal Surveillance Programme
  • John Tapsall Department of Microbiology, The Prince of Wales Hospital, High Street, Randwick, NSW, Australia 2031

DOI:

https://doi.org/10.33321/cdi.2000.24.28

Keywords:

disease surveillance, meningococcal disease, Neisseria meningitidis

Abstract

The National Neisseria Network has undertaken meningococcal isolate surveillance by means of a collaborative laboratory based initiative since 1994. The phenotype (serogroup, serotype and serosubtype) and antibiotic susceptibility of 368 isolates of Neisseria meningitidis from invasive cases of meningococcal disease were determined in 1999. Ninety percent of the invasive isolates were either serogroup B or C. Serogroup B strains predominated in all States and Territories and were isolated from sporadic cases of invasive disease. Serogroup B phenotypes were generally diverse, but in New South Wales phenotype B:4:P1.4(7) became more prominent. The number of serogroup C isolates increased significantly in Victoria and remained prominent in New South Wales, especially in adolescents and adults. Phenotype C:2a:P1.2, infrequently isolated prior to 1999, was the most frequently encountered serogroup C phenotype. A number of infections with a phenotype new to Australia, C:2a:P1.4(7), were noted in Victoria and to a lesser extent in New South Wales. Phenotype C:2a:P1.5 was less frequently encountered than in previous years. About three-quarters of all isolates showed decreased susceptibility to the penicillin group of antibiotics (MIC 0.06 to 0.5 mg/L). Three isolates showed reduced susceptibility to rifampicin. Data relating to 92 laboratory-confirmed but culture-negative cases were included in this report. Some differences in the patterns of disease were revealed when culture-based and non-culture-based data were compared. Commun Dis Intell 2000;24:181-189.

Downloads

Download data is not yet available.

References

Maiden MCJ, Bygraves JA, Feil E, et al. Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci USA 1998;95:3140-3145.

Munro R, Tapsall J. Meningococcal disease in Australia. Commun Dis Intell 1996;20:368-371.

National Neisseria Network. Meningococcal Isolate Surveillance Australia 1994. Commun Dis Intell 1995;19:286-289.

National Neisseria Network. Meningococcal Isolate Surveillance Australia 1995. Commun Dis Intell 1996;20:422-424.

Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 1996. Commun Dis Intell 1997;21:217-221.

Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal surveillance programme, 1997. Commun Dis Intell 1998;22:205-211.

Australian Meningococcal Surveillance Programme. Annual report of the Australian Meningococcal Surveillance Programme, 1998. Commun Dis Intell 1999;23:317-323.

Australian gonococcal surveillance programme. Penicillin sensitivity of gonococci in Australia: development of an Australian gonococcal surveillance programme. Br J Vener Dis 1984;60:226-230.

Porritt RJ, Mercer JL, Munro R. Detection and serogroup determination of Neisseria meningitidis in CSF by polymerase chain reaction (PCR). Pathology 2000;32:42-45.

Kaczmarski EB, Cartwright KAV. Control of meningococcal disease: guidance for microbiologists: CCDC. Consultant in Communicable Disease Control, England. Bur 1995;5:R196-R198.

Jones DM, Kazcmarski EB. Meningococcal infections in England and Wales:1994. Bur 1995;5:R125-R130.

Downloads

Published

31/07/00

How to Cite

Australian Meningococcal Surveillance Programme, and John Tapsall. 2000. “Annual Report of the Australian Meningococcal Surveillance Programme, 1999”. Communicable Diseases Intelligence 24 (July):181-89. https://doi.org/10.33321/cdi.2000.24.28.

Most read articles by the same author(s)

1 2 3 4 5 > >>